Sun 6/16/2019 06:30 ET
DJIA26089.6118.260.07%TELCO173.111.160.67%GOLD1345.351.610.12%Shanghai2881.9728.530.99%
S&P 5002886.984.620.16%BANKS435.691.740.40%OIL52.520.240.46%BITCOIN8635.9257.860.67%
NASDAQ7796.6640.540.52%PHARM570.671.260.22%US/EU1.120.000.01%Futures2891.622.890.10%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search
  
From: SunTzu772 (Rep: 1129)Date: 05/20/2019 15:40
Forum: Wall Street Pit - Msg #2787332Thread #674082535 (Rec: 2)
540k lowest float pharma ever this could be a home run when algos catch on.

"Total payments of Xynomic associated with the licensing agreement, including an upfront payment, regulatory milestone payments and potential royalties, will be up to $800 million."

Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 Ready mTORC1/2 Inhibitor from Boehringer Ingelheim

https://www.prnewswire.com/news-releases/xynomic-pharma-acquires-global-exclusive-rights-to-phase-2-ready-mtorc12-inhibitor-from-boehringer-ingelheim-300769632.html

The stock came down from $10.75 post BCAC merger on 16k shares.



------------------- "Opportunities multiply as they are seized" -- Sun Tzu circa 500 B.C. -------------------

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser SunTzu772: Reward | Watch | Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.